Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating Age-Dependent Oxygenation and Blood Perfusion in a Mouse Model of Peripheral Artery Disease (PAD) Using Multispectral Optoacoustic Tomography (MSOT), Laser Speckle Contrast Imaging (LSCI) and Histology.

Diagnostics (Basel, Switzerland)·2026
Same author

Targeting Tumor-Associated Hypoxia with Bioreductively Activatable Prodrug Conjugates Derived from Dihydronaphthalene, Benzosuberene, and Indole-based Inhibitors of Tubulin Polymerization.

RSC medicinal chemistry·2025
Same author

MRI for biology-guided radiation therapy: Are we there yet? A summary of the 2024 ISMRM member-initiated session.

Magnetic resonance in medicine·2025
Same author

Benzosuberene and Tetracyclic Analogues as Colchicine Site Inhibitors of Tubulin Polymerization.

ACS medicinal chemistry letters·2025
Same author

Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice.

Cancers·2025
Same author

A silicon rhodamine 1,2-dioxetane chemiluminophore for <i>in vivo</i> near-infrared imaging.

Organic & biomolecular chemistry·2025

Related Experiment Video

Updated: Jun 20, 2026

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
07:12

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models

Published on: July 7, 2016

High-throughput quantitative bioluminescence imaging for assessing tumor burden.

Angelina Contero1, Edmond Richer, Ana Gondim

  • 1Cancer Imaging Program, UT Southwestern, Dallas, TX, USA.

Methods in Molecular Biology (Clifton, N.J.)
|August 18, 2009
PubMed
Summary

Bioluminescence imaging (BLI) offers a fast and affordable method for tracking tumor growth and spread in mice. This technique is widely used for evaluating cancer therapies and molecular biology research.

More Related Videos

Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging
11:09

Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging

Published on: July 13, 2010

In vivo Bioluminescent Imaging of Mammary Tumors Using IVIS Spectrum
08:53

In vivo Bioluminescent Imaging of Mammary Tumors Using IVIS Spectrum

Published on: April 29, 2009

Related Experiment Videos

Last Updated: Jun 20, 2026

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
07:12

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models

Published on: July 7, 2016

Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging
11:09

Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging

Published on: July 13, 2010

In vivo Bioluminescent Imaging of Mammary Tumors Using IVIS Spectrum
08:53

In vivo Bioluminescent Imaging of Mammary Tumors Using IVIS Spectrum

Published on: April 29, 2009

Area of Science:

  • Biomedical imaging
  • Preclinical oncology research
  • Molecular biology

Background:

  • Bioluminescence imaging (BLI) has become a leading technique in preclinical research over the last five years.
  • It enables rapid, cost-effective, and straightforward assessment of tumor progression and metastasis in mouse models.
  • Availability of user-friendly instruments and luciferase-expressing tumor cells facilitates its widespread adoption.

Purpose of the Study:

  • To describe routine methods for implementing Bioluminescence Imaging (BLI) in a small animal imaging resource.
  • To highlight the utility of BLI in preclinical cancer research.
  • To showcase BLI's application in assessing therapeutic efficacy and molecular biology questions.

Main Methods:

  • Utilizing subcutaneous and orthotopic tumor models in mice.
  • Employing user-friendly commercial bioluminescence imaging instruments.
  • Incorporating luciferase-expressing tumor cells for high sensitivity detection.
  • Applying BLI for assessing chemotherapeutic efficacy, drug combinations, dosing, and timing.
  • Integrating specific promoter sequences for advanced molecular biology applications.

Main Results:

  • BLI provides high sensitivity and reproducibility in observing both subcutaneous and orthotopic tumor models.
  • Routine use of BLI is increasingly documented for evaluating treatment responses in preclinical studies.
  • The method supports sophisticated molecular biology investigations by allowing promoter-specific imaging.

Conclusions:

  • Bioluminescence imaging is a powerful and versatile tool for preclinical cancer research.
  • Its ease of use, sensitivity, and reproducibility make it ideal for evaluating tumor dynamics and therapeutic interventions.
  • BLI facilitates diverse research applications, from basic tumor monitoring to complex molecular analyses.